Novasky Overseas

Fempro 2.5 mg tablet, containing Letrozole, is an oral aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels, slowing, or stopping cancer cell growth. It is also used to induce ovulation in treating infertility.
Key Details for Fempro 2.5 mg:
Indications: Treatment of early or advanced, hormone receptor-positive breast cancer in postmenopausal women. It is also used off-label for ovulation induction.
Mechanism of Action: Aromatase inhibitor that blocks the enzyme required for estrogen production.
Dosage & Administration: Usually taken as one 2.5mg tablet daily, with or without food.
Side Effects: Common side effects include hot flashes, fatigue, sweating, joint pain (arthralgia), bone thinning (osteoporosis), increased cholesterol, and nausea.
Contraindications: Not for premenopausal women, pregnant women, or breastfeeding mothers.
Monitoring: Regular monitoring of cholesterol levels and bone mineral density is advised.